A Trial of a Preventive Intervention Program for Chilean Families With Depressed Parents

NCT ID: NCT02593266

Last Updated: 2015-11-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-11-30

Study Completion Date

2016-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall aim of this pilot study is to evaluate the acceptability and feasibility of an adaptation of Beardslee's 'Preventive Intervention Program (PIP) for Depression' in Chilean families.

The PIP is a family intervention directed towards strengthening family functioning and enhancing resilience in children of depressed parents. It comprises several modules that work on psycho-education and skill development within the family nucleus.

A single-blind randomized controlled trial will be conducted with two arms, the intervention arm (n=32) which will receive a home-based PIP for depression, and the TAU arm (n=32).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Being a child with depressed parents is associated with poor health and academic outcomes as well as having four times the likelihood of developing a mood disorder compared to children of non-depressed parents.

Objectives: To evaluate acceptability and feasibility of an adaptation of Beardslee's 'Preventive Intervention Program (PIP) for Depression' in Chilean families, and to measure the clinical effects of this intervention.

Participants: Parents with an episode of Depression in the past 3 months with at least one non-depressed child between the ages of 6-12.

Design: single-blind randomized controlled trial with two groups; the intervention group (n=32), which will receive a home-based PIP for depression, and the treatment-as-usual control group (n=32).

Results: Acceptability and feasibility will be measured by determining whether the trial was successfully conducted and well received by the families and preventionists. Recruitment and delivery of the intervention will be assessed as well as whether there was appropriate response and follow-up, and whether the objectives of the study were reached. Secondary outcomes will look at depressive symptoms, family function, psycho-education, parental competence, adaptive behavior and resilience in children.

Follow-up times: T = 0 baseline, T= 2 months (post-intervention), T=5 months, T=8 months, T=11 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Group

weekly sessions of PIP for depression.

Group Type EXPERIMENTAL

Preventive Intervention Program (PIP) for depression

Intervention Type BEHAVIORAL

Manualized intervention designed by Beardslee and colleagues (Beardslee et al., 2003) It is a program based on cognitive behavioural therapy, narrative therapy and systemic therapy. It is divided in 7 modules which are imparted weekly in the family home by 2 'preventionists' (therapists trained to deliver the intervention)

* Module 1: Depression and family
* Module 2: Psychoeducation about depression
* Module 3:The child's perspective on their parent's depression
* Module 4: Skills development
* Module 5: Preparation for the family session
* Module 6: Family session
* Module 7: Revision and future planning
* Follow-up

Waiting list control group

This is treatment as usual.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Preventive Intervention Program (PIP) for depression

Manualized intervention designed by Beardslee and colleagues (Beardslee et al., 2003) It is a program based on cognitive behavioural therapy, narrative therapy and systemic therapy. It is divided in 7 modules which are imparted weekly in the family home by 2 'preventionists' (therapists trained to deliver the intervention)

* Module 1: Depression and family
* Module 2: Psychoeducation about depression
* Module 3:The child's perspective on their parent's depression
* Module 4: Skills development
* Module 5: Preparation for the family session
* Module 6: Family session
* Module 7: Revision and future planning
* Follow-up

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are currently undergoing a depressive episode or have done so in the past 3 months.

Exclusion Criteria

For parents:

* Alcohol or drug dependence or abuse as assessed by the MINI or being in treatment for substance use.
* Psychosis, personality disorder, bipolar disorder or suicide ideation as assessed by the MINI.
* Having a relationship crisis with current partner. Assessed by self-report or by having attended couple's therapy in the past month.
* Attending family therapy.

For children:

* Being outside the age range of 6-12 years at the time of recruitment.
* Intellectual disability
* Having depression as assessed by the MINI Kid
* Being in treatment for a psychiatric disorder or having taken psychotropic medication in the last month.
Minimum Eligible Age

6 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Chile

OTHER

Sponsor Role lead

Harvard Medical School (HMS and HSDM)

OTHER

Sponsor Role collaborator

Boston Children's Hospital

OTHER

Sponsor Role collaborator

Wellesley College

OTHER

Sponsor Role collaborator

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Matias Irarrazaval

Dr. Matias Irarrazaval MD MPH

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Matias Irarrazaval, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Chile

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinica psiquiatrica Universitaria

Santiago, , Chile

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Chile

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Fernanda Prieto, CPsy

Role: CONTACT

+56963335055

Valeria de Angel, MSc

Role: CONTACT

+56957159311

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Fernanda Prieto, CPsy

Role: primary

+56963335055

References

Explore related publications, articles, or registry entries linked to this study.

de Angel V, Prieto F, Gladstone TR, Beardslee WR, Irarrazaval M. The feasibility and acceptability of a preventive intervention programme for children with depressed parents: study protocol for a randomised controlled trial. Trials. 2016 May 6;17(1):237. doi: 10.1186/s13063-016-1348-7.

Reference Type DERIVED
PMID: 27153835 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.fampod.org

Collaborator's website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FONDECYT-11130615

Identifier Type: -

Identifier Source: org_study_id